US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.650
  • -0.040-2.37%
Trading Nov 12 15:33 ET
42.79MMarket Cap-5156P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Anebulo Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q2 -- / 0.000 --
-- 2025/Q1 -- / 0.000 --
-- 2024/Q3 0.000 / 0.000 --
-- 2024/Q2 0.000 / 0.000 --
-- 2024/Q1 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Anebulo Pharmaceuticals Earnings Reports

  • Anebulo Pharmaceuticals | 10-K: FY2024 Annual Report

    Sep 26 04:35

  • Anebulo Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    May 16 10:26

  • Anebulo Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Feb 14 05:38

  • Anebulo Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    Nov 15, 2023 05:30

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 1, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data